Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of Directors Next-generation GABA-aminotransferase (GABA-AT ...
Judy was born to D.L. and Margorie Monk on October 5, 1940, in Jackson. She was in the class of '58 at Provine High School, following graduating in the class of '62 at Millsaps College with a degree ...
Detailed price information for Ovid Therapeutics Inc (OVID-Q) from The Globe and Mail including charting and trades.
Lewy body dementia is often misdiagnosed as Alzheimer disease, despite high specificity of clinical diagnosis.
It’s the second most common type of dementia, after Alzheimer’s, yet many remain unfamiliar with its challenges. “The most common disease that people have never heard of.” That’s how 73-year-old Don ...
All-cause mortality risk was over six times higher for people with young-onset dementia versus controls. Median survival was 8.7 years, but varied by clinical type. People with young-onset ...
RENO, Nev. (KOLO) - Kathy Chan is a local Reno-Tahoe author. She recently published a book that reads like a novel, but is both a memoir and an awareness call to Lewy body Dementia (LBD), which took ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these are certainly symptoms of dementia and Alzheimer’s (the most common form of ...
This valuable work provides new insights into the role of lysine acetylation of alpha-synuclein, the protein involved in Parkinson's Disease. The evidence is mostly solid, but the claims around the ...
Dementia was linked to impairments involving the glymphatic system in a study of 44,000 people. Three markers of CSF dynamics were associated with incident dementia over a median follow-up of 5 years.
The α-synuclein protein can adopt several different conformations that cause neurodegeneration. Different α-synuclein conformers cause at least three distinct α-synucleinopathies: multiple system ...